Suchergebnisse - "Labenz, Christian"

PubPharm (230)

1

Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease : A randomised, controlled proof-of-concept study

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Armandi, A. | Bespaljko, H. | Mang, A. | +8

2

Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2

enthalten in: American journal of physiology. Gastrointestinal and liver physiology | 2024

von Schleicher, E. | Gairing, S. | Castven, D. | +10

3

Resmetirom zur Therapie der NASH mit Fibrose

enthalten in: Gastronews | 2024

von Labenz, C.

4

enthalten in: MMW Fortschritte der Medizin | 2024

von M Schleicher, E. | Labenz, C.

CommentOn: Hepatology. 2023 Oct 1;78(4):1159-1167. - PMID 37066820

5

Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival

enthalten in: Journal of internal medicine | 2024

von Gairing, S. | Mangini, C. | Zarantonello, L. | +14

6

Symptoms, the GerdQ score and patients’ characteristics do not predict gastroesophageal reflux disease in patients with proton-pump-inhibitor-refractory reflux symptoms : results from a large prospective database

Erschienen: Marburg, Philipps-Universität Marburg, 2024

von Labenz, J. | Menzel, M. | Hirsch, O. | +3

7

Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival

enthalten in: Journal of Internal Medicine | 2024

von Gairing, S. | Mangini, C. | Zarantonello, L. | +14

8

Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes

enthalten in: United European Gastroenterology Journal | 2024

von Michel, M. | Doll, M. | Albert, N. | +6

9

Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease : A randomised, controlled proof‐of‐concept study

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Armandi, A. | Bespaljko, H. | Mang, A. | +8

10

Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes

enthalten in: United European gastroenterology journal | 2024

von Michel, M. | Doll, M. | Albert, N. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]